作为抗癌治疗中的免疫调节剂的RORγT激素
Joanna Pastwińska1, Iwona Karwaciak1, Kaja Karaś1
1Laboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Lodz, Poland.
Biochimica et biophysica acta. Reviews on cancer
|November 11, 2023
概括
RORγT激动剂刺激像Th17淋巴细胞这样的免疫细胞,为增强对癌症的免疫反应提供了一条新的途径. 这与反向激动剂形成鲜明对比,反向激动剂通常用于自身免疫性疾病治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 与视网膜相关的孤儿受体gamma t (RORγT) 是一种转录因子,对Th17淋巴细胞发育和IL-17表达细胞至关重要.
- 这些RORγT表达细胞在宿主防御,自身免疫性疾病和癌症免疫力中发挥作用.
- RORγT活动由小分子联结体调节,重点是针对自身免疫性疾病的逆激动剂.
研究的目的:
- 突出RORγT激动剂在治疗应用中的被忽视的潜力.
- 审查RORγT激动剂生物学的最新进展.
- 探索RORγT激动剂在抗癌治疗中的应用.
主要方法:
- 对RORγT生物学和带发育的现有文献的审查.
- 对调查RORγT表达细胞在癌症免疫力中的作用的研究分析.
- 对RORγT激动剂及其机制的最新发现的综合.
主要成果:
- RORγT激动剂可以刺激Th17和Tc17淋巴细胞,增强抗瘤免疫反应.
- 与逆agonists相比,对RORγT激动剂的发展的探索较少.
- 最近的研究提供了对RORγT激动剂的生物活动和治疗潜力的洞察.
结论:
- RORγT激动剂通过增强抗瘤免疫力,代表了癌症治疗的有前途的治疗策略.
- 对RORγT激动剂的进一步研究是有必要的,以充分利用其在瘤学中的潜力.
- 这篇综述强调了RORγT调制在自身免疫性疾病和癌症中的双重作用.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.2K
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.4K
相关概念视频
Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
